Italian Biotech Startup Snelix Secures Over €1 Million in Public Grants for Snail-Mucus Peptide Development
Snelix, an Italian biotech startup that turns snail mucus into bio‑active peptides for cosmeceutical and nutraceutical applications, raised more than €1 million through three public grant schemes, minimizing equity dilution while advancing its product pipeline.